ESG & Investing
Pimco ESG Fund's Fine Print: No Abortion-Related Holdings
- The fund was rebranded years ago but has a faith-based legacy
- The disclosure follows ‘enhanced’ focus on ESG, Pimco says
This article is for subscribers only.
As regulators scrutinize how ESG funds depict themselves and politicians argue over their missions, some managers are making fine-print disclosures that might surprise investors.
Among them: Pacific Investment Management Co., whose largest ESG mutual fund offering in the US has begun spelling out in previously unreported regulatory filings that it doesn’t invest in companies that make money from abortion, contraception and stem cell research.